Consistently with the serum level in OM patients, the other two osteoimmunological biomarkers, DKK-1 (Figure 4i) and SOST (Figure 4l), showed a similar positive correlation with sCD14-ST (r2 = 0.892 and r2 = 0.925, respectively). This evidence concerns the gene SOST and ocular melanoma.